Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
6.
Klin Monbl Augenheilkd ; 207(1): 37-41, 1995 Jul.
Article in German | MEDLINE | ID: mdl-7564136

ABSTRACT

BACKGROUND: The vascular factor is becoming increasingly important in the pathogenesis of primary open-angle glaucoma. Ocular hypotonia, which is indubitably a risk factor in the development of glaucoma, cannot be regarded as the sole pathogenic factor. Clinical experience leaves no doubt that some patients tolerate a high IOP for prolonged periods of time without ocular damage. In others, however, severe glaucoma-related lesions result from slight hypertonia or critically low pressure. METHODS: The authors analyze the general factors which influence ocular blood flow and increase the deleterious effect of ocular hypertonia, and report results relating to the hemodynamic status of a group of glaucoma patients prior to and after one year of therapy with beta-blockers. The results are analyzed and discussed.


Subject(s)
Eye/blood supply , Glaucoma, Open-Angle/physiopathology , Intraocular Pressure/physiology , Adrenergic beta-Antagonists/therapeutic use , Blood Flow Velocity/drug effects , Blood Flow Velocity/physiology , Blood Pressure/drug effects , Blood Pressure/physiology , Follow-Up Studies , Glaucoma, Open-Angle/drug therapy , Homeostasis/drug effects , Homeostasis/physiology , Humans , Intraocular Pressure/drug effects , Parasympathomimetics/therapeutic use , Regional Blood Flow/drug effects , Regional Blood Flow/physiology , Signal Processing, Computer-Assisted/instrumentation , Tonometry, Ocular/instrumentation
7.
Surv Ophthalmol ; 38 Suppl: S118-24, 1994 May.
Article in English | MEDLINE | ID: mdl-7940133

ABSTRACT

In the past several years the effect of longterm glaucoma therapy on ocular hemodynamics has taken on increased interest. This interest has been sparked by studies demonstrating differential effects of various beta-blockers on visual function, and the possible contributory role of ocular blood flow. In the present study, the pulsatile ocular blood flow (POBF), as derived by the Langham OBF system, was measured prior to treatment and then tracked throughout a one-year period of beta-blocker therapy (betaxolol 0.5% or timolol 0.5%) in 25 glaucoma patients. Results of the two treatments were compared, and indicated that, whereas both betaxolol- and timolol-treated patients had similar significant reductions in the IOP, the effect of the two treatments on the POBF differed. In timolol-treated patients, the POBF decreased significantly over the 12-month observation period, whereas in betaxolol-treated patients it remained stable.


Subject(s)
Betaxolol/therapeutic use , Glaucoma, Open-Angle/drug therapy , Timolol/therapeutic use , Adult , Aged , Aged, 80 and over , Betaxolol/pharmacology , Blood Flow Velocity/drug effects , Blood Flow Velocity/physiology , Female , Glaucoma, Open-Angle/physiopathology , Humans , Intraocular Pressure , Longitudinal Studies , Male , Middle Aged , Pulsatile Flow/drug effects , Pulsatile Flow/physiology , Timolol/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...